Li Auto Posts Sharp Rise In Li ONE Sales For Q2; Stocks Up In Pre-market

Li Auto Inc. (LI), a Chinese electric vehicle maker, said on Friday that it has reported a significant rise in the sales of its Li ONE, a six-seat premium electric SUV for the second quarter and for the month of June.

For the quarter, the automaker delivered 28,687 units of Li ONE, a rise of 63.2 percent compared with the same period last year.

For the month of June, the company sold 13,024 units of the model, up 68.9 percent compared with the same month of 2021.

The cumulative deliveries of Li ONE have reached 184,491 since the vehicle's market debut in 2019.

Shares of Li Auto were trading up 2.09 percent at $38.31 in pre-market on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT